SpringWorks Therapeutics Inc. (SWTX) NASDAQ

$67.59 -0.89 (-1.30%)

Market Cap: $3.37B

As of 11/29/21 03:59 PM EST. Market closed.

(SWTX)

SpringWorks Therapeutics Inc. (SWTX) NASDAQ

$67.59 -0.89 (-1.30%)

Market Cap: $3.37B

As of 11/29/21 03:59 PM EST. Market closed.

SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. SpringWorks has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially ... read more

SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. SpringWorks has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers. SpringWorks' strategic approach and operational excellence in clinical development have enabled it to rapidly advance its two lead product candidates into late-stage clinical trials while simultaneously entering into multiple shared-value partnerships with industry leaders to expand its portfolio. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
78
Address
.
KEY STATS
Open
$67.59
Previous Close
$68.48
Days Range
$65.97 - $71.13
52 week range
$51.72 - $96.48
Volume
381,065
Avg. Volume (30 days)
277,140
Market Cap
$3.37B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
49,249,215
Open
$67.59
Previous Close
$68.48
Days Range
$65.97 - $71.13
52 week range
$51.72 - $96.48
Volume
381,065
Avg. Volume (30 days)
277,140
Market Cap
$3.37B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
49,249,215

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SPRINGWORKS THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Islam Saqib Chief Executive Officer Oct 20, 2021 Sale $58.67 10,083 591,527 779,218 Oct 20, 2021, 07:14 PM
Islam Saqib Chief Executive Officer Oct 19, 2021 Sale $58.81 14,077 827,873 769,135 Oct 19, 2021, 07:27 PM
Islam Saqib Chief Executive Officer Oct 18, 2021 Sale $58.59 38,340 2,246,505 783,212 Oct 19, 2021, 07:27 PM
Smith L. Mary Chief Development Officer Oct 13, 2021 Option Exercise $2.30 10,000 23,000 177,511 Oct 13, 2021, 08:24 PM
Smith L. Mary Chief Development Officer Oct 13, 2021 Sale $55.97 10,000 559,675 167,511 Oct 13, 2021, 08:24 PM
Pichl Daniel Chief People Officer Sep 08, 2021 Option Exercise $43.10 2,320 99,992 9,236 Sep 09, 2021, 05:15 PM
Bain Capital Life Sciences Investors, LLC 10% Owner Aug 10, 2021 Sale $70.25 1,000,000 70,250,000 4,831,307 Aug 12, 2021, 08:38 PM
Islam Saqib Chief Executive Officer Jul 20, 2021 Sale $77.68 18,572 1,442,751 821,552 Jul 20, 2021, 07:34 PM
Islam Saqib Chief Executive Officer Jul 19, 2021 Sale $76.09 43,928 3,342,437 840,124 Jul 20, 2021, 07:34 PM
Smith L. Mary Chief Development Officer Jul 13, 2021 Option Exercise $2.30 10,000 23,000 177,511 Jul 14, 2021, 04:28 PM
Smith L. Mary Chief Development Officer Jul 13, 2021 Sale $80.88 10,000 808,777 167,511 Jul 14, 2021, 04:28 PM
ORBIMED ADVISORS LLC 10% Owner Jul 01, 2021 Sale $85.01 15,959 1,356,675 6,028,307 Jul 06, 2021, 04:42 PM
Edris Badreddin Chief Operating Officer Jul 01, 2021 Sale $85.35 32,000 2,731,088 301,541 Jul 01, 2021, 06:30 PM
ORBIMED ADVISORS LLC 10% Owner Jun 28, 2021 Sale $85.17 6,502 553,775 6,044,266 Jun 30, 2021, 09:01 PM
ORBIMED ADVISORS LLC 10% Owner Jun 24, 2021 Sale $85.22 34,200 2,914,524 6,073,102 Jun 25, 2021, 07:11 PM
ORBIMED ADVISORS LLC 10% Owner Jun 23, 2021 Sale $85.00 100 8,500 6,107,302 Jun 25, 2021, 07:11 PM
ORBIMED ADVISORS LLC 10% Owner Jun 25, 2021 Sale $85.14 22,334 1,901,517 6,050,768 Jun 25, 2021, 07:11 PM
SQUINTO STEPHEN P Director Apr 28, 2021 Sale $76.20 19,231 1,465,437 125,728 Apr 28, 2021, 08:18 PM
SQUINTO STEPHEN P Director Apr 27, 2021 Sale $75.05 201 15,085 144,959 Apr 28, 2021, 08:18 PM
Islam Saqib Chief Executive Officer Apr 20, 2021 Sale $66.39 24,075 1,598,279 884,052 Apr 20, 2021, 06:51 PM
Islam Saqib Chief Executive Officer Apr 19, 2021 Sale $69.04 38,425 2,652,827 908,127 Apr 20, 2021, 06:51 PM
SQUINTO STEPHEN P Director Apr 15, 2021 Sale $75.01 1,057 79,291 145,160 Apr 19, 2021, 06:07 AM
SQUINTO STEPHEN P Director Apr 14, 2021 Sale $75.08 511 38,365 146,217 Apr 19, 2021, 06:07 AM
Smith L. Mary Chief Development Officer Apr 13, 2021 Option Exercise $2.30 10,000 23,000 177,511 Apr 13, 2021, 08:21 PM
Smith L. Mary Chief Development Officer Apr 13, 2021 Sale $68.07 10,000 680,723 167,511 Apr 13, 2021, 08:21 PM
Bain Capital Life Sciences Investors, LLC 10% Owner Mar 09, 2021 Sale $71.50 1,450,000 103,675,000 5,831,307 Mar 11, 2021, 04:30 PM
ORBIMED ADVISORS LLC 10% Owner Mar 01, 2021 Sale $83.19 1,220,000 101,491,803 6,186,307 Mar 03, 2021, 06:55 PM
Edris Badreddin Chief Operating Officer Jan 25, 2021 Sale $84.07 32,000 2,690,281 261,542 Jan 26, 2021, 04:31 PM
Smith L. Mary Chief Development Officer Jan 20, 2021 Option Exercise $2.23 10,000 22,267 177,511 Jan 21, 2021, 04:31 PM
Smith L. Mary Chief Development Officer Jan 20, 2021 Sale $78.70 10,000 787,016 167,511 Jan 21, 2021, 04:31 PM
Islam Saqib Chief Executive Officer Jan 20, 2021 Sale $78.75 2,199 173,180 1,222,997 Jan 21, 2021, 04:30 PM
Islam Saqib Chief Executive Officer Jan 19, 2021 Sale $78.54 60,301 4,736,209 1,225,196 Jan 21, 2021, 04:30 PM
Lewis-Hall Freda C Director Sep 17, 2019 Buy $18.00 50,000 900,000 4,593,847 Sep 19, 2019, 07:12 PM
ORBIMED ADVISORS LLC 10% Owner Sep 17, 2019 Buy $18.00 275,000 4,950,000 7,406,307 Sep 19, 2019, 07:12 PM
SQUINTO STEPHEN P Director Sep 17, 2019 Buy $18.00 275,000 4,950,000 7,406,307 Sep 19, 2019, 07:12 PM
Bain Capital Life Sciences Investors, LLC 10% Owner Sep 17, 2019 Buy $18.00 150,000 2,700,000 7,281,307 Sep 19, 2019, 07:05 PM
PFIZER INC 10% Owner Sep 17, 2019 Buy $18.00 50,000 900,000 4,593,847 Sep 19, 2019, 04:19 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Islam Saqib Chief Executive Officer 10/20/2021 591,527
Islam Saqib Chief Executive Officer 10/19/2021 827,873
Islam Saqib Chief Executive Officer 10/18/2021 2,246,505
Smith L. Mary Chief Development Officer 10/13/2021 23,000
Smith L. Mary Chief Development Officer 10/13/2021 559,675
Pichl Daniel Chief People Officer 09/08/2021 99,992
Bain Capital Life Sciences Investors, LLC 10% Owner 08/10/2021 70,250,000
Islam Saqib Chief Executive Officer 07/20/2021 1,442,751
Islam Saqib Chief Executive Officer 07/19/2021 3,342,437
Smith L. Mary Chief Development Officer 07/13/2021 23,000
Smith L. Mary Chief Development Officer 07/13/2021 808,777
ORBIMED ADVISORS LLC 10% Owner 07/01/2021 1,356,675
Edris Badreddin Chief Operating Officer 07/01/2021 2,731,088
ORBIMED ADVISORS LLC 10% Owner 06/28/2021 553,775
ORBIMED ADVISORS LLC 10% Owner 06/24/2021 2,914,524
ORBIMED ADVISORS LLC 10% Owner 06/23/2021 8,500
ORBIMED ADVISORS LLC 10% Owner 06/25/2021 1,901,517
SQUINTO STEPHEN P Director 04/28/2021 1,465,437
SQUINTO STEPHEN P Director 04/27/2021 15,085
Islam Saqib Chief Executive Officer 04/20/2021 1,598,279
Islam Saqib Chief Executive Officer 04/19/2021 2,652,827
SQUINTO STEPHEN P Director 04/15/2021 79,291
SQUINTO STEPHEN P Director 04/14/2021 38,365
Smith L. Mary Chief Development Officer 04/13/2021 23,000
Smith L. Mary Chief Development Officer 04/13/2021 680,723
Bain Capital Life Sciences Investors, LLC 10% Owner 03/09/2021 103,675,000
ORBIMED ADVISORS LLC 10% Owner 03/01/2021 101,491,803
Edris Badreddin Chief Operating Officer 01/25/2021 2,690,281
Smith L. Mary Chief Development Officer 01/20/2021 22,267
Smith L. Mary Chief Development Officer 01/20/2021 787,016
Islam Saqib Chief Executive Officer 01/20/2021 173,180
Islam Saqib Chief Executive Officer 01/19/2021 4,736,209
Lewis-Hall Freda C Director 09/17/2019 900,000
ORBIMED ADVISORS LLC 10% Owner 09/17/2019 4,950,000
SQUINTO STEPHEN P Director 09/17/2019 4,950,000
Bain Capital Life Sciences Investors, LLC 10% Owner 09/17/2019 2,700,000
PFIZER INC 10% Owner 09/17/2019 900,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
06/30/2021
0.19%
1Q
09/30/2021
03/31/2021
0.39%
2Q
09/30/2021
12/31/2020
11.82%
3Q
09/30/2021
09/30/2020
15.38%
4Q
09/30/2021
06/30/2020
15.65%
5Q
09/30/2021
03/31/2020
15.86%
6Q
Load More

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
0.19%
1Q
03/31/2021
0.39%
2Q
12/31/2020
11.82%
3Q
09/30/2020
15.38%
4Q
06/30/2020
15.65%
5Q
03/31/2020
15.86%
6Q
Load More